Literature DB >> 16641432

Proteomic study of peptide deformylase inhibition in Streptococcus pneumoniae and Staphylococcus aureus.

Wen Wang1, Richard White, Zhengyu Yuan.   

Abstract

Peptide deformylase (PDF) is an essential enzyme in both gram-negative and gram-positive bacteria. It hydrolyzes formylated N-terminal peptides to generate free N-terminal peptides during the process of protein maturation. Inhibition of this enzyme results in cessation of bacterial growth. We have examined the effect of a potent PDF inhibitor, LBM-415 (also known as VIC-104959), on the proteomes of Staphylococcus aureus and Streptococcus pneumoniae using two-dimensional electrophoresis. Both S. aureus and S. pneumoniae showed accumulation of many N-terminal formylated peptides/proteins upon PDF inhibition. In S. pneumoniae, formylated peptide/protein accumulation was time dependent. Following inhibition, subsequent removal of the inhibitor resulted in deformylation of formylated peptides/proteins; this recovery process was also time dependent. If instead the inhibited cells were maintained in the presence of sub-MIC levels of the PDF inhibitor, the formylated peptides/proteins remained for a much longer time, which correlated with a prolonged postantibiotic effect in vitro. These observations may have broader implications for the application of this class of antibiotics in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641432      PMCID: PMC1472206          DOI: 10.1128/AAC.50.5.1656-1663.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms.

Authors:  C Giglione; A Serero; M Pierre; B Boisson; T Meinnel
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 2.  Peptide deformylase as a target for new generation, broad spectrum antimicrobial agents.

Authors:  C Giglione; M Pierre; T Meinnel
Journal:  Mol Microbiol       Date:  2000-06       Impact factor: 3.501

3.  Deformylase as a novel antibacterial target.

Authors:  Z Yuan; J Trias; R J. White
Journal:  Drug Discov Today       Date:  2001-09-15       Impact factor: 7.851

4.  Proteomic approach to understanding antibiotic action.

Authors:  Julia Elisabeth Bandow; Heike Brötz; Lars Ingo Ole Leichert; Harald Labischinski; Michael Hecker
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

5.  The role of peptide deformylase in protein biosynthesis: a proteomic study.

Authors:  Julia Elisabeth Bandow; Dörte Becher; Knut Büttner; Falko Hochgräfe; Christoph Freiberg; Heike Brötz; Michael Hecker
Journal:  Proteomics       Date:  2003-03       Impact factor: 3.984

6.  Removal of formyl-methionine residue from nascent bacteriophage f2 protein.

Authors:  D Housman; D Gillespie; H F Lodish
Journal:  J Mol Biol       Date:  1972-03-14       Impact factor: 5.469

7.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.

Authors:  B N Kreiswirth; S Löfdahl; M J Betley; M O'Reilly; P M Schlievert; M S Bergdoll; R P Novick
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

Review 8.  Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.

Authors:  R Jain; D Chen; R J White; D V Patel; Z Yuan
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

9.  Characterization of a human peptide deformylase: implications for antibacterial drug design.

Authors:  Kiet T Nguyen; Xubo Hu; Craig Colton; Ratna Chakrabarti; Michael X Zhu; Dehua Pei
Journal:  Biochemistry       Date:  2003-08-26       Impact factor: 3.162

10.  Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation.

Authors:  D Mazel; S Pochet; P Marlière
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  5 in total

1.  Solvent-assisted slow conversion of a dithiazole derivative produces a competitive inhibitor of peptide deformylase.

Authors:  Alexander K Berg; Qingfeng Yu; Steven Y Qian; Manas K Haldar; D K Srivastava
Journal:  Biochim Biophys Acta       Date:  2009-11-14

2.  Drug forecast - the peptide deformylase inhibitors as antibacterial agents.

Authors:  David R P Guay
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

3.  Formyl-methionine as a degradation signal at the N-termini of bacterial proteins.

Authors:  Konstantin I Piatkov; Tri T M Vu; Cheol-Sang Hwang; Alexander Varshavsky
Journal:  Microb Cell       Date:  2015

4.  The ORFeome of Staphylococcus aureus v 1.1.

Authors:  Christina J Brandner; Richard H Maier; Daryl S Henderson; Helmut Hintner; Johann W Bauer; Kamil Onder
Journal:  BMC Genomics       Date:  2008-07-07       Impact factor: 3.969

5.  Aureolib - a proteome signature library: towards an understanding of staphylococcus aureus pathophysiology.

Authors:  Stephan Fuchs; Daniela Zühlke; Jan Pané-Farré; Harald Kusch; Carmen Wolf; Swantje Reiß; Le Thi Nguyen Binh; Dirk Albrecht; Katharina Riedel; Michael Hecker; Susanne Engelmann
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.